In a move to cut costs, Peregrine Pharmaceuticals has reduced its overall workforce by 60 employees (or 20%). The company says it expects the workforce reductions to result in a net cost savings of between $3.7 million and $4.3 million in fiscal year 2018 and more than $7 million in reduced annualized operating expenses beginning in fiscal year 2019. As part of the cost saving initiatives, the company reduced Peregrine’s R&D personnel by 50% to 11 employees, with the remaining staff...